Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.666 EUR 1.71% Market Closed
Market Cap: 106.2m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

Oryzon Genomics SA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oryzon Genomics SA
Capital Expenditures Peer Comparison

Comparables:
GRF
PHM
BST

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Oryzon Genomics SA
MAD:ORY
Capital Expenditures
-€14.5m
CAGR 3-Years
-16%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Capital Expenditures
-€295.4m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Pharma Mar SA
MAD:PHM
Capital Expenditures
-€20.1m
CAGR 3-Years
-61%
CAGR 5-Years
-98%
CAGR 10-Years
-10%
Biotechnology Assets SA
MAD:BST
Capital Expenditures
-€326k
CAGR 3-Years
6%
CAGR 5-Years
51%
CAGR 10-Years
N/A

See Also

What is Oryzon Genomics SA's Capital Expenditures?
Capital Expenditures
-14.5m EUR

Based on the financial report for Dec 31, 2023, Oryzon Genomics SA's Capital Expenditures amounts to -14.5m EUR.

What is Oryzon Genomics SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-16%

Over the last year, the Capital Expenditures growth was -2%. The average annual Capital Expenditures growth rates for Oryzon Genomics SA have been -16% over the past three years , -16% over the past five years .

Back to Top